The House Energy and Commerce Health Subcommittee today opened a two-day hearing on 25 bills designed to address the opioid crisis. Witnesses from the Food and Drug Administration, the Centers for Disease Control and Prevention, and the Substance Abuse and Mental Health Services Administration outlined steps their agencies are taking to address the epidemic. Witnesses from The Kennedy Forum, Community Anti-Drug Coalitions of America, Biotechnology Innovation Organization, Association for Accessible Medicines, and DisposeRx also testified. AHA is weighing in on the bills with the committee. Chairmen of the relevant committees in Congress have said they hope to enact comprehensive legislation by Memorial Day. The subcommittee hearing will continue tomorrow with testimony from additional witnesses. 

Related News Articles

Headline
The National Academies of Sciences Engineering, and Medicine yesterday released recommendations for improving outcomes and metrics associated with four grant…
Headline
The Centers for Medicare & Medicaid Services recently announced a six-month delay in implementation of its Innovation Center Maternal Opioid Misuse (MOM)…
Headline
Mallinckrodt Pharmaceuticals today announced an agreement in principle on a settlement to resolve all opioid-related claims against the company in…
Headline
Public and private entities can apply for $1 million grants for a three-year period to enhance or expand opioid and other substance use disorder services in…
Headline
Rep. Vicky Hartzler, R-Mo., House Energy and Commerce Committee Ranking Member Greg Walden, R-Ore., and other Republicans on the committee last week asked the…
Headline
The House Energy and Commerce Subcommittee on Oversight and Investigations today held a hearing to highlight how federal funds have helped states combat…